South Dakota House of Representatives bill in Session 71.
Status: enacted. Latest action: March 10, 2026.
reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.
An Act to reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.
| Date | Event | Detail |
|---|---|---|
| 2026-01-20 | Introduced | Bill introduced |
| 2026-03-10 | Status | enacted |
| 2026-03-10 | Latest Action | Signed by the Governor |